33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world effectiveness of approved anticancer agents among Medicare beneficiaries
    Meeting Abstract

    Green, A.; Curry, M. A.; Bach, P.; Mailankody, S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up
    Meeting Abstract

    Guminski, A. D.; Lim, A. M. L.; Khushalani, N. I.; Schmults, C. D.; Hernandez-Aya, L. F.; Modi, B.; Dunn, L.; Hughes, B. G. M.; Chang, A. L. S.; Hauschild, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Advanced cancer patients' changes in terminal illness understanding (TIU) and their psychological well-being
    Meeting Abstract

    George, L. S.; Shen, M. J.; Maciejewski, P. K.; Epstein, A. S.; Prigerson, H. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC) - First experimental arm (EA) initial results
    Meeting Abstract

    George, T. J.; Yothers, G.; Hong, T. S.; Russell, M. M.; You, Y. N.; Parker, W.; Jacobs, S. A.; Lucas, P. C.; Gollub, M. J.; Hall, W. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First experience of LOXO-292 in the management of pediatric patients with RET-altered cancers
    Meeting Abstract

    Gerdemann, U.; Lee, Y. A.; Henry, D.; Smith, S.; Ortiz, M. V.; Rothenberg, S. M.; Raju, S. G.; Cox, M. C.; Glade Bender, J. L.; Pappo, A. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab
    Meeting Abstract

    Georges, S.; Shah, P. K.; Shapiro, I.; Hicking, C.; Lu, L.; Hennessy, M.; D'Angelo, S. P.; Cai, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pexidartinib for advanced tenosynovial giant cell tumor (TGCT): Long-term efficacy and safety from the phase 3 ENLIVEN and phase 1 PLX108-01 (TGCT cohort) studies
    Meeting Abstract

    Gelderblom, H.; Tap, W. D.; Palmerini, E.; Stacchiotti, S.; Wainberg, Z. A.; Desai, J.; Healey, J. H.; van de Sande, M.; Bernthal, N. M.; Peterfy, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of postoperative treatment with concurrent chemoradiotherapy (CRT) in high risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration
    Meeting Abstract

    Geiger, J. L.; Woody, N. M.; Tsai, C. J.; Ghanem, A. I.; Dunlap, N.; Liu, H.; Burkey, B. B.; Lamarre, E.; Ku, J.; Scharpf, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save